Recent advances in intra-articular drug delivery systems for osteoarthritis therapy

P Maudens, O Jordan, E Allémann - Drug discovery today, 2018 - Elsevier
Highlights•Precision medicine is necessary to treat multiple facets of osteoarthritis.•Disease-
modifying osteoarthritis drugs (DMOADs) and drug delivery systems (DDSs) are …

Knee osteoarthritis therapy: recent advances in intra-articular drug delivery systems

L Ma, X Zheng, R Lin, ARJ Sun, J Song… - Drug design …, 2023 - Taylor & Francis
Drug delivery for osteoarthritis (OA) treatment is a continuous challenge because of their
poor bioavailability and rapid clearance in joints. Intra-articular (IA) drug delivery is a …

PCL and PCL-based materials in biomedical applications

E Malikmammadov, TE Tanir, A Kiziltay… - Journal of …, 2018 - Taylor & Francis
Biodegradable polymers have met with an increasing demand in medical usage over the
last decades. One of such polymers is poly (ε-caprolactone)(PCL), which is a polyester that …

Machine learning models to accelerate the design of polymeric long-acting injectables

P Bannigan, Z Bao, RJ Hickman, M Aldeghi… - Nature …, 2023 - nature.com
Long-acting injectables are considered one of the most promising therapeutic strategies for
the treatment of chronic diseases as they can afford improved therapeutic efficacy, safety …

[HTML][HTML] Injectable polymeric nanoparticle hydrogel system for long-term anti-inflammatory effect to treat osteoarthritis

BB Seo, Y Kwon, J Kim, KH Hong, SE Kim, HR Song… - Bioactive materials, 2022 - Elsevier
Abstract Treatment of osteoarthritis (OA) by administration of corticosteroids is a commonly
used method in clinics using anti-inflammatory medicine. Oral administration or intra …

Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy

L Kou, S Xiao, R Sun, S Bao, Q Yao, R Chen - Drug delivery, 2019 - Taylor & Francis
Osteoarthritis (OA) is a progressive and degenerative disease, which is no longer confined
to the elderly. So far, current treatments are limited to symptom relief, and no valid OA …

Skin targeting by chitosan/hyaluronate hybrid nanoparticles for the management of irritant contact dermatitis: In vivo therapeutic efficiency in mouse-ear dermatitis …

KE Abuelella, H Abd-Allah, SM Soliman… - International Journal of …, 2023 - Elsevier
Irritant contact dermatitis (ICD) is an inflammatory skin condition characterized by severe
eczematous lesions. Nanoparticulate drug delivery is the most predominant way to improve …

[HTML][HTML] Thermo-and pH-dual responsive polymeric micelles with upper critical solution temperature behavior for photoacoustic imaging-guided synergistic chemo …

Z Yang, R Cheng, C Zhao, N Sun, H Luo, Y Chen… - Theranostics, 2018 - ncbi.nlm.nih.gov
Chemo-photothermal therapy shows great potential for inhibiting tumor growth. However,
achieving maximal chemo-photothermal synergistic efficacy is challenging because of the …

Targeted treatment for osteoarthritis: drugs and delivery system

L Mao, W Wu, M Wang, J Guo, H Li, S Zhang, J Xu… - Drug …, 2021 - Taylor & Francis
The management of osteoarthritis (OA) is a clinical challenge due to the particular avascular,
dense, and occluded tissue structure. Despite numerous clinical reports and animal studies …

Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities

YC Chen, SF Gad, D Chobisa, Y Li, Y Yeo - Journal of Controlled Release, 2021 - Elsevier
Inflammation that is not resolved in due course becomes a chronic disease. The treatment of
chronic inflammatory diseases involves a long-term use of anti-inflammatory drugs such as …